GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Stella Diagnostics Inc (OTCPK:SLDX) » Definitions » Pre-Tax Income

Stella Diagnostics (Stella Diagnostics) Pre-Tax Income : $ Mil (TTM As of Sep. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Stella Diagnostics Pre-Tax Income?

Pretax income is the income that a company earns before paying income taxes. Stella Diagnostics's pretax income for the three months ended in Sep. 2023 was $-0.82 Mil. Stella Diagnostics does not have enough years/quarters to calculate the pretax income for the trailing twelve months (TTM) ended in Sep. 2023. Stella Diagnostics's pretax margin was %.


Stella Diagnostics Pre-Tax Income Historical Data

The historical data trend for Stella Diagnostics's Pre-Tax Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Stella Diagnostics Pre-Tax Income Chart

Stella Diagnostics Annual Data
Trend
Pre-Tax Income

Stella Diagnostics Quarterly Data
Sep22 Sep23
Pre-Tax Income -0.73 -0.82

Competitive Comparison of Stella Diagnostics's Pre-Tax Income

For the Diagnostics & Research subindustry, Stella Diagnostics's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Stella Diagnostics's Pre-Tax Income Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Stella Diagnostics's Pre-Tax Income distribution charts can be found below:

* The bar in red indicates where Stella Diagnostics's Pre-Tax Income falls into.



Stella Diagnostics Pre-Tax Income Calculation

This is the income that a company earns before paying income taxes.

Stella Diagnostics's Pretax Income for the fiscal year that ended in . 20 is calculated as

Stella Diagnostics's Pretax Income for the quarter that ended in Sep. 2023 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=-0.395+-0.382+-0.039+0+1.1102230246252E-16
=-0.82

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Stella Diagnostics  (OTCPK:SLDX) Pre-Tax Income Explanation

Stella Diagnostics's Pretax Margin for the quarter that ended in Sep. 2023 is calculated as

Pretax Margin=Pretax Income/Revenue
=-0.816/0
=%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Stella Diagnostics Pre-Tax Income Related Terms

Thank you for viewing the detailed overview of Stella Diagnostics's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.


Stella Diagnostics (Stella Diagnostics) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
50 West Broadway, Suite 300, Salt Lake City, UT, USA, 84104
Stella Diagnostics Inc is a molecular diagnostics-based organization focused on improving patient management strategies for people living with severe esophageal disease. It is developing first-line diagnostic tools that provide superior molecular information for providers as compared to the current standard screening protocols.

Stella Diagnostics (Stella Diagnostics) Headlines

From GuruFocus